{"id":"https://openalex.org/A5082696040","orcid":"https://orcid.org/0000-0002-0667-8328","observed_orcids":["https://orcid.org/0000-0002-0667-8328"],"display_name":"Martin Juha\u0161\u010dik","raw_author_names":["Juha\u0161\u010dik, Martin","Martin Juha\u0161\u010dik"],"full_name":"Juha\u0161\u010dik, Martin","works_count":8,"cited_by_count":95,"summary_stats":{"2yr_mean_citedness":0.3333333333333333,"h_index":3,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5082696040","orcid":"https://orcid.org/0000-0002-0667-8328","observed_orcids":["https://orcid.org/0000-0002-0667-8328"]},"affiliations":[{"institution":{"id":"https://openalex.org/I21250087","ror":"https://ror.org/024d6js02","display_name":"Charles University","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},"years":[2023,2020]},{"institution":{"id":"https://openalex.org/I4210119000","ror":"https://ror.org/02fzn1g05","display_name":"Contipro (Czechia)","country_code":"CZ","type":"company","lineage":["https://openalex.org/I4210119000"]},"years":[2026,2023,2022]},{"institution":{"id":"https://openalex.org/I75092371","ror":"https://ror.org/05k238v14","display_name":"University of Hradec Kr\u00e1lov\u00e9","country_code":"CZ","type":"education","lineage":["https://openalex.org/I75092371"]},"years":[2022]}],"last_known_institutions":[{"id":"https://openalex.org/I4210119000","ror":"https://ror.org/02fzn1g05","display_name":"Contipro (Czechia)","country_code":"CZ","type":"company","lineage":["https://openalex.org/I4210119000"]}],"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","count":7,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10407","display_name":"Lipid Membrane Structure and Behavior","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","count":3,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":2,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","value":4.96e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13012","display_name":"Coenzyme Q10 studies and effects","value":4.53e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","value":3.36e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","value":2.33e-05,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10407","display_name":"Lipid Membrane Structure and Behavior","value":1.16e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2777851122","wikidata":"https://www.wikidata.org/wiki/Q424213","display_name":"Ceramide","score":0.8785272836685181},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.858299970626831},{"id":"171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","score":0.6230369210243225},{"id":"12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","score":0.47119998931884766},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.3111000061035156}],"counts_by_year":[{"year":2019,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2020,"works_count":2,"oa_works_count":2,"cited_by_count":2},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":8},{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":20},{"year":2024,"works_count":1,"oa_works_count":0,"cited_by_count":21},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":19},{"year":2026,"works_count":2,"oa_works_count":1,"cited_by_count":23}],"display_name_alternatives":["Juha\u0161\u010dik, Martin","Martin Juha\u0161\u010dik"],"block_key":"m juhascik","works_api_url":"https://api.openalex.org/works?filter=author.id:A5082696040","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5082696040","updated_date":"2026-11-11T13:02:13","created_date":"2020-06-12T00:00:00"}